BioGaia AB (publ)
BGLAF
$8.87
-$0.8517-8.76%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 8.41% | 9.91% | 7.27% | 12.06% | 7.47% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.41% | 9.91% | 7.27% | 12.06% | 7.47% |
| Cost of Revenue | 10.39% | 13.29% | 5.98% | 7.67% | 4.98% |
| Gross Profit | 7.69% | 8.68% | 7.73% | 13.71% | 8.40% |
| SG&A Expenses | 14.71% | 15.52% | 11.31% | 10.71% | 8.31% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 291.88% | -- | -- | -- | -- |
| Total Operating Expenses | 14.29% | 11.11% | 5.26% | 5.23% | 5.67% |
| Operating Income | -3.16% | 7.60% | 11.25% | 26.69% | 11.18% |
| Income Before Tax | -16.84% | -4.35% | -18.44% | 1.16% | -7.23% |
| Income Tax Expenses | -14.93% | -6.76% | -0.54% | 24.18% | 12.69% |
| Earnings from Continuing Operations | -17.36% | -3.67% | -22.37% | -3.77% | -11.47% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -17.36% | -3.67% | -22.37% | -3.77% | -11.47% |
| EBIT | -3.16% | 7.60% | 11.25% | 26.69% | 11.18% |
| EBITDA | -2.71% | 7.24% | 10.77% | 24.92% | 10.43% |
| EPS Basic | -17.43% | -3.69% | -22.37% | -3.78% | -11.46% |
| Normalized Basic EPS | -6.14% | 5.85% | 10.10% | 22.49% | 12.41% |
| EPS Diluted | -17.58% | -3.78% | -22.40% | -3.75% | -11.44% |
| Normalized Diluted EPS | -6.14% | 5.85% | 10.10% | 22.49% | 12.41% |
| Average Basic Shares Outstanding | 0.11% | 0.07% | 0.02% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.12% | 0.08% | 0.03% | 0.01% | 0.00% |
| Dividend Per Share | 1.18% | 1.18% | 31.98% | 31.98% | 31.98% |
| Payout Ratio | 1.83% | 1.43% | 2.02% | 1.43% | 0.03% |